As per CRI’s report, the sequencing reagents market in North America is assessed to display a CAGR of 12.61% over the predicted years 2021-2028. The United States and Canada outline the market in this region.
The COVID-19 outbreak created several growth opportunities for the genomics segment in the biotechnology sector in the US. In this regard, the practices of genomic applications, such as SARS-CoV-2 virus surveillance, have significantly grown since the beginning of the pandemic. However, other practices like non-invasive prenatal genetic testing, DNA-based forensics, direct-to-consumer ancestry investigating, and genetic disease diagnostics are majorly conducted following the launch of the Human Genome Project. Besides, genomics has emerged as the preferred scientific research for microbiology and oncology. Thus, these developments are supporting the growth of the sequencing reagents market in the US.
On the other hand, Canada is organizing several events and conferences to offer an open platform to strengthen synthetic biology and its application. For instance, 10x Genomics invested significantly in the development and launch of new products, along with an expansion of its commercial operations. Besides, Canada SynBio, the first national conference on synthetic biology, was conducted to unite professors, students, industry leaders, and policymakers across the country to discuss success stories relating to genomics and gene synthesis. Hence, these initiatives are responsible for the robust growth of the sequencing reagents market growth.

COMPETITIVE OUTLOOK

The distinguished companies in the sequencing reagents market are LGC Biosearch Technologies, Qiagen NV, BGI Genomics, Agilent Technologies Inc, Takara Bio Inc, Perkinelmer Inc, and Trilink Biotechnologies Inc

TABLE OF CONTENTS

1. NORTH AMERICA SEQUENCING REAGENTS MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON SEQUENCING REAGENTS MARKET
2.2. KEY INSIGHTS
2.3. PORTER’S FIVE FORCES MODEL
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. COMPETITIVE RIVALRY
2.4. SUPPLY CHAIN OUTLOOK
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. KEY STRATEGIC DEVELOPMENTS
2.7.1. CONTRACTS AND PARTNERSHIPS
2.7.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.7.3. ACQUISITIONS & MERGERS
2.7.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS
2.8. MARKET DRIVERS
2.8.1. ONGOING RESEARCH ON GENOMICS DUE TO THE PREVALENCE OF CHRONIC DISEASES
2.8.2. ADVANCES IN GENOMICS AFTER THE LAUNCH OF NEW TECHNOLOGIES
2.9. MARKET CHALLENGES
2.9.1. SOCIAL AND ETHICAL ISSUES RELATED TO DATA PRIVACY
2.10. MARKET OPPORTUNITIES
2.10.1. FUNDING BY MANUFACTURERS AND GOVERNMENT IN GENOMICS
2.10.2. GROWING DEMAND FOR THIRD-GENERATION SEQUENCING
3. NORTH AMERICA SEQUENCING REAGENTS MARKET – BY APPLICATION
3.1. ONCOLOGY
3.2. CLINICAL INVESTIGATION
3.3. AGRI GENOMICS AND FORENSICS
3.4. REPRODUCTIVE HEALTH
3.5. OTHER APPLICATIONS
4. NORTH AMERICA SEQUENCING REAGENTS MARKET – BY REAGENT TYPE
4.1. SEQUENCING KITS
4.2. CONTROL KITS
4.3. LIBRARY KITS
4.4. TEMPLATE KITS
4.5. OTHER REAGENT TYPES
5. NORTH AMERICA SEQUENCING REAGENTS MARKET – BY TECHNOLOGY
5.1. NEXT-GENERATION SEQUENCING
5.2. SANGER SEQUENCING
5.3. THIRD-GENERATION SEQUENCING
6. NORTH AMERICA SEQUENCING REAGENTS MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH INSTITUTES
6.2. HOSPITALS AND CLINICS
6.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
6.4. OTHER INDUSTRY VERTICALS
7. NORTH AMERICA SEQUENCING REAGENTS MARKET – COUNTRY OUTLOOK
7.1. COUNTRY ANALYSIS
7.1.1. UNITED STATES
7.1.2. CANADA
8. COMPANY PROFILE
8.1. AGILENT TECHNOLOGIES INC
8.2. ASURAGEN INC
8.3. BGI GENOMICS
8.4. BIO RAD LABORATORIES INC
8.5. F HOFFMANN LA ROCHE
8.6. FLUIDIGM CORPORATION
8.7. ILLUMINA INC
8.8. LGC BIOSEARCH TECHNOLOGIES
8.9. MERCK KGAA
8.10. PACIFIC BIOSCIENCES OF CALIFORNIA INC
8.11. PERKINELMER INC
8.12. QIAGEN NV
8.13. TAKARA BIO INC
8.14. THERMO FISHER SCIENTIFIC INC
8.15. TRILINK BIOTECHNOLOGIES INC
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1. OBJECTIVES OF STUDY
9.1.2. SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1. PRIMARY DATA SOURCES
9.2.2. SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1. EVALUATION OF PROPOSED MARKET
9.3.2. IDENTIFICATION OF DATA SOURCES
9.3.3. ASSESSMENT OF MARKET DETERMINANTS
9.3.4. DATA COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS

LIST OF TABLES

TABLE 1: NORTH AMERICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 4: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS & MERGERS
TABLE 6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 2: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 3: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY CLINICAL INVESTIGATION, 2021-2028 (IN $ MILLION)
FIGURE 4: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY AGRI GENOMICS AND FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 5: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2020 & 2028 (IN %)
FIGURE 8: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY SEQUENCING KITS, 2021-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY LIBRARY KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY TEMPLATE KITS, 2021-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY OTHER REAGENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 14: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY NEXT-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY SANGER SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY THIRD-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 18: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 19: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY HOSPITALS AND CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 22: UNITED STATES SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: CANADA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)

The post NORTH AMERICA SEQUENCING REAGENTS MARKET 2021-2028 first appeared on CRI Report.

According to CRI’s report, the global sequencing reagents market is assessed to observe a growth trend at a CAGR of 12.83% based on revenue through the considered period 2021-2028.

The ongoing research in genomics due to the rise in chronic diseases, along with the advancement in genomics following the launch of new technologies, are driving the studied market on a growth path. Additionally, investments by manufacturers and governments in genomics are opening new avenues for the market globally.

Conversely, social and ethical issues relating to data privacy and the lack of professionals in developing regions impede the overall growth of the sequencing reagents market.

REGIONAL OUTLOOK

The global sequencing reagents market comprises the Asia-Pacific, North America, Latin America, Europe, and the Middle East and Africa regions.
Geographically, the Asia-Pacific is estimated to emerge as the fastest evolving region in the sequencing reagents market over the reviewed period. The region’s robust growth can be attributed to the surging investments by government bodies across the major countries.

Moreover, the increase in research and development of genomics is another factor contributing to the studied market’s growth. For instance, the Indian government has introduced initiatives for startups in the biotechnology sector, which will ultimately foster the growth of the sequencing reagents market.

COMPETITIVE OUTLOOK

The key companies thriving in the sequencing reagents market are F Hoffmann La Roche, Illumina Inc, Perkinelmer Inc, Qiagen NV, Bio Rad Laboratories Inc, Trilink Biotechnologies Inc, Asuragen Inc, Merck KGAA, Agilent Technologies Inc, BGI Genomics, Thermo Fisher Scientific Inc, Fluidigm Corporation, Pacific Biosciences of California Inc, Takara Bio Inc, and LGC Biosearch Technologies.

Thermo Fisher Scientific Inc is a leading company operating under various business segments, such as laboratory products & services, analytical instruments, specialty diagnostics, and life sciences solutions. It develops and delivers its products to research institutes, government agencies, universities, hospitals, and pharmaceutical companies, among others. Founded in 2006, Thermo Fisher has a presence across more than 50 nations. It is headquartered in Massachusetts, the United States.

TABLE OF CONTENTS

1. GLOBAL SEQUENCING REAGENTS MARKET – SUMMARY

2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON SEQUENCING REAGENTS MARKET
2.2. KEY INSIGHTS
2.3. PORTER’S FIVE FORCES MODEL
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. COMPETITIVE RIVALRY
2.4. SUPPLY CHAIN OUTLOOK
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. KEY STRATEGIC DEVELOPMENTS
2.7.1. CONTRACTS AND PARTNERSHIPS
2.7.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.7.3. ACQUISITIONS & MERGERS
2.7.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS
2.8. MARKET DRIVERS
2.8.1. ONGOING RESEARCH IN GENOMICS DUE TO THE PREVALENCE OF CHRONIC DISEASES
2.8.2. ADVANCES IN GENOMICS AFTER THE LAUNCH OF NEW TECHNOLOGIES
2.9. MARKET CHALLENGES
2.9.1. SOCIAL AND ETHICAL ISSUES RELATED TO DATA PRIVACY
2.9.2. LACK OF PROFESSIONALS IN DEVELOPING COUNTRIES
2.10. MARKET OPPORTUNITIES
2.10.1. FUNDING BY MANUFACTURERS AND GOVERNMENT IN GENOMICS
2.10.2. GROWING DEMAND FOR THIRD-GENERATION SEQUENCING

3. GLOBAL SEQUENCING REAGENTS MARKET – BY APPLICATION
3.1. ONCOLOGY
3.2. CLINICAL INVESTIGATION
3.3. AGRI GENOMICS AND FORENSICS
3.4. REPRODUCTIVE HEALTH
3.5. OTHER APPLICATIONS

4. GLOBAL SEQUENCING REAGENTS MARKET – BY REAGENT TYPE
4.1. SEQUENCING KITS
4.2. CONTROL KITS
4.3. LIBRARY KITS
4.4. TEMPLATE KITS
4.5. OTHER REAGENT TYPES

5. GLOBAL SEQUENCING REAGENTS MARKET – BY TECHNOLOGY
5.1. NEXT-GENERATION SEQUENCING
5.2. SANGER SEQUENCING
5.3. THIRD-GENERATION SEQUENCING

6. GLOBAL SEQUENCING REAGENTS MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH INSTITUTES
6.2. HOSPITALS AND CLINICS
6.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
6.4. OTHER INDUSTRY VERTICALS

7. GLOBAL SEQUENCING REAGENTS MARKET – REGIONAL OUTLOOK
7.1. NORTH AMERICA
7.1.1. MARKET BY APPLICATION
7.1.2. MARKET BY REAGENT TYPE
7.1.3. MARKET BY TECHNOLOGY
7.1.4. MARKET BY INDUSTRY VERTICALS
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET BY APPLICATION
7.2.2. MARKET BY REAGENT TYPE
7.2.3. MARKET BY TECHNOLOGY
7.2.4. MARKET BY INDUSTRY VERTICALS
7.2.5. COUNTRY ANALYSIS
7.2.5.1. GERMANY
7.2.5.2. FRANCE
7.2.5.3. UNITED KINGDOM
7.2.5.4. ITALY
7.2.5.5. RUSSIA
7.2.5.6. SPAIN
7.2.5.7. REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET BY APPLICATION
7.3.2. MARKET BY REAGENT TYPE
7.3.3. MARKET BY TECHNOLOGY
7.3.4. MARKET BY INDUSTRY VERTICALS
7.3.5. COUNTRY ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. INDIA
7.3.5.4. AUSTRALIA & NEW ZEALAND
7.3.5.5. SOUTH KOREA
7.3.5.6. ASEAN COUNTRIES
7.3.5.7. REST OF ASIA-PACIFIC
7.4. LATIN AMERICA
7.4.1. MARKET BY APPLICATION
7.4.2. MARKET BY REAGENT TYPE
7.4.3. MARKET BY TECHNOLOGY
7.4.4. MARKET BY INDUSTRY VERTICALS
7.4.5. COUNTRY ANALYSIS
7.4.5.1. BRAZIL
7.4.5.2. MEXICO
7.4.5.3. REST OF LATIN AMERICA
7.5. MIDDLE EAST AND AFRICA
7.5.1. MARKET BY APPLICATION
7.5.2. MARKET BY REAGENT TYPE
7.5.3. MARKET BY TECHNOLOGY
7.5.4. MARKET BY INDUSTRY VERTICALS
7.5.5. COUNTRY ANALYSIS
7.5.5.1. SAUDI ARABIA
7.5.5.2. UNITED ARAB EMIRATES
7.5.5.3. TURKEY
7.5.5.4. SOUTH AFRICA
7.5.5.5. REST OF MIDDLE EAST & AFRICA

8. COMPANY PROFILE
8.1. AGILENT TECHNOLOGIES INC
8.2. ASURAGEN INC
8.3. BGI GENOMICS
8.4. BIO RAD LABORATORIES INC
8.5. F HOFFMANN LA ROCHE
8.6. FLUIDIGM CORPORATION
8.7. ILLUMINA INC
8.8. LGC BIOSEARCH TECHNOLOGIES
8.9. MERCK KGAA
8.10. PACIFIC BIOSCIENCES OF CALIFORNIA INC
8.11. PERKINELMER INC
8.12. QIAGEN NV
8.13. TAKARA BIO INC
8.14. THERMO FISHER SCIENTIFIC INC
8.15. TRILINK BIOTECHNOLOGIES INC

9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1. OBJECTIVES OF STUDY
9.1.2. SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1. PRIMARY DATA SOURCES
9.2.2. SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1. EVALUATION OF PROPOSED MARKET
9.3.2. IDENTIFICATION OF DATA SOURCES
9.3.3. ASSESSMENT OF MARKET DETERMINANTS
9.3.4. DATA COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS

LIST OF TABLES

TABLE 1: GLOBAL SEQUENCING REAGENTS MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 4: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS & MERGERS
TABLE 6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: GLOBAL SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 11: GLOBAL SEQUENCING REAGENTS MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 17: EUROPE SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 18: EUROPE SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 19: EUROPE SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 20: EUROPE SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 21: EUROPE SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 23: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 24: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 25: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 27: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 28: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 29: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 30: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 31: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 32: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 33: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 34: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 35: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: GLOBAL SEQUENCING REAGENTS MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 2: GLOBAL SEQUENCING REAGENTS MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 3: GLOBAL SEQUENCING REAGENTS MARKET, BY CLINICAL INVESTIGATION, 2021-2028 (IN $ MILLION)
FIGURE 4: GLOBAL SEQUENCING REAGENTS MARKET, BY AGRI GENOMICS AND FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 5: GLOBAL SEQUENCING REAGENTS MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 6: GLOBAL SEQUENCING REAGENTS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2020 & 2028 (IN %)
FIGURE 8: GLOBAL SEQUENCING REAGENTS MARKET, BY SEQUENCING KITS, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL SEQUENCING REAGENTS MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL SEQUENCING REAGENTS MARKET, BY LIBRARY KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL SEQUENCING REAGENTS MARKET, BY TEMPLATE KITS, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL SEQUENCING REAGENTS MARKET, BY OTHER REAGENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 14: GLOBAL SEQUENCING REAGENTS MARKET, BY NEXT-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL SEQUENCING REAGENTS MARKET, BY SANGER SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL SEQUENCING REAGENTS MARKET, BY THIRD-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 18: GLOBAL SEQUENCING REAGENTS MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL SEQUENCING REAGENTS MARKET, BY HOSPITALS AND CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 20: GLOBAL SEQUENCING REAGENTS MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL SEQUENCING REAGENTS MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 22: UNITED STATES SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: CANADA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: GERMANY SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: FRANCE SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: UNITED KINGDOM SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: ITALY SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: RUSSIA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: SPAIN SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: REST OF EUROPE SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 31: CHINA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 32: JAPAN SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 33: INDIA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 34: AUSTRALIA & NEW ZEALAND SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 35: SOUTH KOREA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 36: ASEAN COUNTRIES SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 37: REST OF ASIA-PACIFIC SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 38: BRAZIL SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 39: MEXICO SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 40: REST OF LATIN AMERICA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 41: SAUDI ARABIA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 42: UNITED ARAB EMIRATES SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 43: TURKEY SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 44: SOUTH AFRICA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 45: REST OF MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)

The post GLOBAL SEQUENCING REAGENTS MARKET 2021-2028 first appeared on CRI Report.

CRI’s report on the sequencing reagents market states that the market in Europe is expected to thrive at a compound annual growth rate of 13.00% based on value during the projected period 2021-2028. Germany, Italy, Spain, France, Russia, the United Kingdom, and Rest of Europe shape the region’s market.
The United Kingdom is advancing its healthcare sector at a rapid pace. There is a surge in government initiatives, leading to a rise in R&D activities and an increase in specialized therapies relating to cancer and autoimmune diseases. Here, the growing prevalence of cancer is estimated to fuel the studied market’s growth. For instance, the country witnessed a rise in oncology, breast cancer, colorectal cancer, and skin melanoma in 2020. This surged the need for specialized therapies significantly, influencing the demand for sequencing reagents. Thus, these factors are expected to widen the scope and development of the sequencing reagents market.
On the other hand, the sequencing reagents market is likely to gain a significant share in Italy, owing to the high prevalence of chronic diseases, especially cancer. As per estimates, the country observed a substantial growth in oncology, breast cancer, and other cancer cases, which surged the need for sequencing reagents. Besides, the rising awareness relating to the benefits of sequencing reagents for cancer treatments has boosted the growth of the sequencing reagents market across the country to a large extent.

COMPETITIVE OUTLOOK

The major companies in the sequencing reagents market are Illumina Inc, Fluidigm Corporation, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Takara Bio Inc, Asuragen Inc, and Merck KGAA

TABLE OF CONTENTS

1. EUROPE SEQUENCING REAGENTS MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON SEQUENCING REAGENTS MARKET
2.2. KEY INSIGHTS
2.3. PORTER’S FIVE FORCES MODEL
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. COMPETITIVE RIVALRY
2.4. SUPPLY CHAIN OUTLOOK
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. KEY STRATEGIC DEVELOPMENTS
2.7.1. CONTRACTS AND PARTNERSHIPS
2.7.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.7.3. ACQUISITIONS & MERGERS
2.7.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS
2.8. MARKET DRIVERS
2.8.1. ONGOING RESEARCH IN GENOMICS DUE TO THE PREVALENCE OF CHRONIC DISEASES
2.8.2. ADVANCES IN GENOMICS AFTER THE LAUNCH OF NEW TECHNOLOGIES
2.9. MARKET CHALLENGES
2.9.1. SOCIAL AND ETHICAL ISSUES RELATED TO DATA PRIVACY
2.10. MARKET OPPORTUNITIES
2.10.1. FUNDING BY MANUFACTURERS AND GOVERNMENT IN GENOMICS
2.10.2. GROWING DEMAND FOR THIRD-GENERATION SEQUENCING
3. EUROPE SEQUENCING REAGENTS MARKET – BY APPLICATION
3.1. ONCOLOGY
3.2. CLINICAL INVESTIGATION
3.3. AGRI GENOMICS AND FORENSICS
3.4. REPRODUCTIVE HEALTH
3.5. OTHER APPLICATIONS
4. EUROPE SEQUENCING REAGENTS MARKET – BY REAGENT TYPE
4.1. SEQUENCING KITS
4.2. CONTROL KITS
4.3. LIBRARY KITS
4.4. TEMPLATE KITS
4.5. OTHER REAGENT TYPES
5. EUROPE SEQUENCING REAGENTS MARKET – BY TECHNOLOGY
5.1. NEXT-GENERATION SEQUENCING
5.2. SANGER SEQUENCING
5.3. THIRD-GENERATION SEQUENCING
6. EUROPE SEQUENCING REAGENTS MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH INSTITUTES
6.2. HOSPITALS AND CLINICS
6.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
6.4. OTHER INDUSTRY VERTICALS
7. EUROPE SEQUENCING REAGENTS MARKET – COUNTRY OUTLOOK
7.1. COUNTRY ANALYSIS
7.1.1. GERMANY
7.1.2. FRANCE
7.1.3. THE UNITED KINGDOM
7.1.4. ITALY
7.1.5. RUSSIA
7.1.6. SPAIN
7.1.7. REST OF EUROPE
8. COMPANY PROFILE
8.1. AGILENT TECHNOLOGIES INC
8.2. ASURAGEN INC
8.3. BGI GENOMICS
8.4. BIO RAD LABORATORIES INC
8.5. F HOFFMANN LA ROCHE
8.6. FLUIDIGM CORPORATION
8.7. ILLUMINA INC
8.8. LGC BIOSEARCH TECHNOLOGIES
8.9. MERCK KGAA
8.10. PACIFIC BIOSCIENCES OF CALIFORNIA INC
8.11. PERKINELMER INC
8.12. QIAGEN NV
8.13. TAKARA BIO INC
8.14. THERMO FISHER SCIENTIFIC INC
8.15. TRILINK BIOTECHNOLOGIES INC
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1. OBJECTIVES OF STUDY
9.1.2. SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1. PRIMARY DATA SOURCES
9.2.2. SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1. EVALUATION OF PROPOSED MARKET
9.3.2. IDENTIFICATION OF DATA SOURCES
9.3.3. ASSESSMENT OF MARKET DETERMINANTS
9.3.4. DATA COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS

LIST OF TABLES
TABLE 1: EUROPE SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 4: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS & MERGERS
TABLE 6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: EUROPE SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 8: EUROPE SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: EUROPE SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 11: EUROPE SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

LIST OF FIGURES
FIGURE 1: EUROPE SEQUENCING REAGENTS MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 2: EUROPE SEQUENCING REAGENTS MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 3: EUROPE SEQUENCING REAGENTS MARKET, BY CLINICAL INVESTIGATION, 2021-2028 (IN $ MILLION)
FIGURE 4: EUROPE SEQUENCING REAGENTS MARKET, BY AGRI GENOMICS AND FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 5: EUROPE SEQUENCING REAGENTS MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 6: EUROPE SEQUENCING REAGENTS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 7: EUROPE SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2020 & 2028 (IN %)
FIGURE 8: EUROPE SEQUENCING REAGENTS MARKET, BY SEQUENCING KITS, 2021-2028 (IN $ MILLION)
FIGURE 9: EUROPE SEQUENCING REAGENTS MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 10: EUROPE SEQUENCING REAGENTS MARKET, BY LIBRARY KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: EUROPE SEQUENCING REAGENTS MARKET, BY TEMPLATE KITS, 2021-2028 (IN $ MILLION)
FIGURE 12: EUROPE SEQUENCING REAGENTS MARKET, BY OTHER REAGENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 13: EUROPE SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 14: EUROPE SEQUENCING REAGENTS MARKET, BY NEXT-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: EUROPE SEQUENCING REAGENTS MARKET, BY SANGER SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 16: EUROPE SEQUENCING REAGENTS MARKET, BY THIRD-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 17: EUROPE SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 18: EUROPE SEQUENCING REAGENTS MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 19: EUROPE SEQUENCING REAGENTS MARKET, BY HOSPITALS AND CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 20: EUROPE SEQUENCING REAGENTS MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 21: EUROPE SEQUENCING REAGENTS MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 22: GERMANY SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: FRANCE SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: UNITED KINGDOM SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: ITALY SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: RUSSIA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: SPAIN SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: REST OF EUROPE SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)

The post EUROPE SEQUENCING REAGENTS MARKET 2021-2028 first appeared on CRI Report.

According to CRI’s report, it is calculated that the sequencing reagents market in Latin America will grow at a CAGR of 11.81% based on revenue during the assessed years of 2021-2028. Brazil, Mexico, and Rest of Latin America shape the overall market in this region.

In Brazil, the biotechnology industry has witnessed several activities in the healthcare and industrial sectors. Moreover, the country is known for its research and investment in industrial biotechnology, mainly relating to cellulosic sugars and agribusiness. Several stakeholders, policymakers, and public investors have promoted the advancement of industrial biotechnology across the country.

Additionally, the trade groups in the country aim to improve the present patent laws to support biotechnology advancements, R&D, laboratory infrastructures, and others. Thus, the growth in biotechnology is anticipated to widen the scope of the sequencing reagents market.

Further, Mexico is striving to adopt new genomics techniques. Several local organizations are conducting seminars across the country to increase awareness about new genomic technologies.

For instance, the Center for Genomic Sciences and the Institute of Biotechnology introduced a series of seminars called ‘Frontiers in Genomics.’ It discusses functional, evolutionary, bacterial, computational, and human genomics, along with experimental analysis and technology. Therefore, efforts to raise awareness relating to developments in genomics are likely to offer opportunities to the sequencing reagents market in Mexico.

COMPETITIVE OUTLOOK

Major firms in the sequencing reagents market are Asuragen Inc, Merck KGAA, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Illumina Inc, Fluidigm Corporation, and Takara Bio Inc.

TABLE OF CONTENTS

1. LATIN AMERICA SEQUENCING REAGENTS MAREKT – SUMMARY

2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON SEQUENCING REAGENTS MARKET
2.2. KEY INSIGHTS
2.3. PORTER’S FIVE FORCES MODEL
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING POWER OF BUYERSDS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. COMPETITIVE RIVALRY
2.4. SUPPLY CHAIN OUTLOOK
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. KEY STRATEGIC DEVELOPMENTS
2.7.1. CONTRACTS AND PARTNERSHIPS
2.7.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.7.3. ACQUISITIONS & MERGERS
2.7.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS
2.8. MARKET DRIVERS
2.8.1. ONGOING RESEARCH IN GENOMICS DUE TO THE PREVALENCE OF CHRONIC DISEASES
2.8.2. ADVANCES IN GENOMICS AFTER THE LAUNCH OF NEW TECHNOLOGIES
2.9. MARKET CHALLENGES
2.9.1. SOCIAL AND ETHICAL ISSUES RELATED TO DATA PRIVACY
2.9.2. LACK OF PROFESSIONALS IN DEVELOPING COUNTRIES
2.10. MARKET OPPORTUNITIES
2.10.1. FUNDING BY MANUFACTURERS AND GOVERNMENT IN GENOMICS
2.10.2. GROWING DEMAND FOR THIRD-GENERATION SEQUENCING

3. LATIN AMERICA SEQUENCING REAGENTS MARKET – BY APPLICATION
3.1. ONCOLOGY
3.2. CLINICAL INVESTIGATION
3.3. AGRI GENOMICS AND FORENSICS
3.4. REPRODUCTIVE HEALTH
3.5. OTHER APPLICATIONS

4. LATIN AMERICA SEQUENCING REAGENTS MARKET – BY REAGENT TYPE
4.1. SEQUENCING KITS
4.2. CONTROL KITS
4.3. LIBRARY KITS
4.4. TEMPLATE KITS
4.5. OTHER REAGENT TYPES

5. LATIN AMERICA SEQUENCING REAGENTS MARKET – BY TECHNOLOGY
5.1. NEXT-GENERATION SEQUENCING
5.2. SANGER SEQUENCING
5.3. THIRD-GENERATION SEQUENCING

6. LATIN AMERICA SEQUENCING REAGENTS MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH INSTITUTES
6.2. HOSPITALS AND CLINICS
6.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
6.4. OTHER INDUSTRY VERTICALS

7. LATIN AMERICA SEQUENCING REAGENTS MARKET – COUNTRY OUTLOOK
7.1. COUNTRY ANALYSIS
7.1.1. BRAZIL
7.1.2. MEXICO
7.1.3. REST OF LATIN AMERICA

8. COMPANY PROFILE
8.1. AGILENT TECHNOLOGIES INC
8.2. ASURAGEN INC
8.3. BGI GENOMICS
8.4. BIO RAD LABORATORIES INC
8.5. F HOFFMANN-LA ROCHE
8.6. FLUIDIGM CORPORATION
8.7. ILLUMINA INC
8.8. LGC BIOSEARCH TECHNOLOGIES
8.9. MERCK KGAA
8.10. PACIFIC BIOSCIENCES OF CALIFORNIA INC
8.11. PERKINELMER INC
8.12. QIAGEN NV
8.13. TAKARA BIO INC
8.14. THERMO FISHER SCIENTIFIC INC
8.15. TRILINK BIOTECHNOLOGIES INC

9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1. OBJECTIVES OF STUDY
9.1.2. SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1. PRIMARY DATA SOURCES
9.2.2. SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1. EVALUATION OF PROPOSED MARKET
9.3.2. IDENTIFICATION OF DATA SOURCES
9.3.3. ASSESSMENT OF MARKET DETERMINANTS
9.3.4. DATA COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS

LIST OF TABLES

TABLE 1: LATIN AMERICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 4: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS & MERGERS
TABLE 6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 8: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 10: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 11: LATIN AMERICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 2: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 3: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY CLINICAL INVESTIGATION, 2021-2028 (IN $ MILLION)
FIGURE 4: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY AGRI GENOMICS AND FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 5: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 6: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 7: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2020 & 2028 (IN %)
FIGURE 8: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY SEQUENCING KITS, 2021-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 10: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY LIBRARY KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY TEMPLATE KITS, 2021-2028 (IN $ MILLION)
FIGURE 12: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY OTHER REAGENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 14: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY NEXT-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY SANGER SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 16: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY THIRD-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 17: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 18: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 19: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY HOSPITALS AND CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 20: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 21: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 22: BRAZIL SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: MEXICO SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: REST OF LATIN AMERICA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)

The post LATIN AMERICA SEQUENCING REAGENTS MARKET 2021-2028 first appeared on CRI Report.

CRI’s report displays that the Middle East and Africa sequencing reagents market is probable to witness progress at a CAGR of 11.51% over the forecast period 2021-2028. South Africa, Turkey, the UAE, Saudi Arabia, and Rest of Middle East & Africa outline the market in this region.

Turkey is projected to have moderate growth in the sequencing reagents market owing to the development in biotechnology. Recently, the government announced the Biosafety Decisions on import of genetically engineered soybean and corn events. Additionally, the high prevalence of cancer and autoimmune diseases demands specialized therapies, which significantly contributes to the growth of the studied market.

For instance, approximately 65 people are diagnosed with lung cancer each day in the country. As per estimates, these numbers are likely to increase between 2023 and 2050. Hence, the factors are estimated to amplify the demand for sequencing reagents, thereby driving the sequencing reagents market on a growth path.

Furthermore, several market players are adopting organic and inorganic growth strategies to influence the market’s growth in South Africa. For instance, the South African Medical Research Council launched the African Genomics Center, becoming the first high-throughput genome sequencing center.

The MGI genetic sequencer has been installed and tested in the research center, providing solid support in refining the science of genomics for precision medicine development. Thus, these factors are motivating the development of the South African sequencing reagents market.

COMPETITIVE OUTLOOK

Some of the major companies profiled in the sequencing reagents market include Merck KGAA, BGI Genomics, Perkinelmer Inc, LGC Biosearch Technologies, Takara Bio Inc, Trilink Biotechnologies Inc, and Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

1. MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET – SUMMARY

2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON SEQUENCING REAGENTS MARKET
2.2. KEY INSIGHTS
2.3. PORTER’S FIVE FORCES MODEL
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING POWER OF BUYERSDS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. COMPETITIVE RIVALRY
2.4. SUPPLY CHAIN OUTLOOK
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. KEY STRATEGIC DEVELOPMENTS
2.7.1. CONTRACTS AND PARTNERSHIPS
2.7.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.7.3. ACQUISITIONS & MERGERS
2.7.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS
2.8. MARKET DRIVERS
2.8.1. ONGOING RESEARCH IN GENOMICS DUE TO THE PREVALENCE OF CHRONIC DISEASES
2.8.2. ADVANCES IN GENOMICS AFTER THE LAUNCH OF NEW TECHNOLOGIES
2.9. MARKET CHALLENGES
2.9.1. SOCIAL AND ETHICAL ISSUES RELATED TO DATA PRIVACY
2.9.2. LACK OF PROFESSIONALS IN DEVELOPING COUNTRIES
2.10. MARKET OPPORTUNITIES
2.10.1. FUNDING BY MANUFACTURERS AND GOVERNMENT IN GENOMICS
2.10.2. GROWIN DEMAND FOR THIRD-GENERATION SEQUENCING

3. MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET – BY APPLICATION
3.1. ONCOLOGY
3.2. CLINICAL INVESTIGATION
3.3. AGRI GENOMICS AND FORENSICS
3.4. REPRODUCTIVE HEALTH
3.5. OTHER APPLICATIONS

4. MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET – BY REAGENT TYPE
4.1. SEQUENCING KITS
4.2. CONTROL KITS
4.3. LIBRARY KITS
4.4. TEMPLATE KITS
4.5. OTHER REAGENT TYPES

5. MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET – BY TECHNOLOGY
5.1. NEXT-GENERATION SEQUENCING
5.2. SANGER SEQUENCING
5.3. THIRD-GENERATION SEQUENCING

6. MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH INSTITUTES
6.2. HOSPITALS AND CLINICS
6.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
6.4. OTHER INDUSTRY VERTICALS

7. MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET – COUNTRY OUTLOOK
7.1. COUNTRY ANALYSIS
7.1.1. SAUDI ARABIA
7.1.2. UNITED ARAB EMIRATES
7.1.3. TURKEY
7.1.4. SOUTH AFRICA
7.1.5. REST OF MIDDLE EAST & AFRICA

8. COMPANY PROFILE
8.1. AGILENT TECHNOLOGIES INC
8.2. ASURAGEN INC
8.3. BGI GENOMICS
8.4. BIO RAD LABORATORIES INC
8.5. F HOFFMANN-LA ROCHE
8.6. FLUIDIGM CORPORATION
8.7. ILLUMINA INC
8.8. LGC BIOSEARCH TECHNOLOGIES
8.9. MERCK KGAA
8.10. PACIFIC BIOSCIENCES OF CALIFORNIA INC
8.11. PERKINELMER INC
8.12. QIAGEN NV
8.13. TAKARA BIO INC
8.14. THERMO FISHER SCIENTIFIC INC
8.15. TRILINK BIOTECHNOLOGIES INC

9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1. OBJECTIVES OF STUDY
9.1.2. SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1. PRIMARY DATA SOURCES
9.2.2. SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1. EVALUATION OF PROPOSED MARKET
9.3.2. IDENTIFICATION OF DATA SOURCES
9.3.3. ASSESSMENT OF MARKET DETERMINANTS
9.3.4. DATA COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS

LIST OF TABLES

TABLE 1: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 4: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS & MERGERS
TABLE 6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 8: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 10: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 11: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 2: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 3: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY CLINICAL INVESTIGATION, 2021-2028 (IN $ MILLION)
FIGURE 4: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY AGRI GENOMICS AND FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 5: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2020 & 2028 (IN %)
FIGURE 8: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY SEQUENCING KITS, 2021-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY LIBRARY KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY TEMPLATE KITS, 2021-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY OTHER REAGENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 14: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY NEXT-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY SANGER SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY THIRD-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 17: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 18: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY HOSPITALS AND CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 20: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 21: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 22: SAUDI ARABIA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: UNITED ARAB EMIRATES SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: TURKEY SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: SOUTH AFRICA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: REST OF MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)

The post MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET 2021-2028 first appeared on CRI Report.

CRI’s report estimates that the Asia-Pacific sequencing reagents market is anticipated to witness growth at a CAGR of 13.35% during the years 2021-2028. South Korea, India, Japan, Australia & New Zealand, ASEAN countries, China, and Rest of APAC form the market in this region.

In India, the government fosters innovations, start-ups, and entrepreneurship under the Start-up India program by the Ministry of Science & Technology. The focus is primarily on building the start-up innovation ecosystem. In this regard, activities are supported by various governmental bodies.

Other than this, several start-ups are working on localized genomics data to offer cancer treatments. For instance, 4BaseCare provides personalized cancer care solutions designed based on the risk level for an individual. Moreover, several international companies are offering funds to these companies. Hence, as stated above, the governmental support and rising innovative steps by companies are likely to fuel the growth of the sequencing reagents market in India.

Further, genomic medicine is gaining momentum across South Korea, as the country hosts one of the largest biobanks globally. Genetic testing is rising for hereditary diseases and cancer diagnoses to personalize treatments. Earlier, the Seoul National University Hospital collaborated with Syapse to develop the leading precision medicine platform in the country. Besides, the largest Personal Genome Project was launched in the country to map complete genomic diversity among the citizens, construct a gene variation database, and offer full genome information for the growing genomic industry. Thus, such developments boost the growth of the sequencing reagents market significantly.

COMPETITIVE OUTLOOK

Leading companies in the sequencing reagents market are Merck KGAA, LGC Biosearch Technologies, Pacific Biosciences of California Inc, Fluidigm Corporation, Thermo Fisher Scientific Inc, Takara Bio Inc, and BGI Genomics

TABLE OF CONTENTS

1. ASIA-PACIFIC SEQUENCING REAGENTS MARKET – SUMMARY

2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON SEQUENCING REAGENTS MARKET
2.2. KEY INSIGHTS
2.3. PORTER’S FIVE FORCES MODEL
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. COMPETITIVE RIVALRY
2.4. SUPPLY CHAIN OUTLOOK
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. KEY STRATEGIC DEVELOPMENTS
2.7.1. CONTRACTS AND PARTNERSHIPS
2.7.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.7.3. ACQUISITIONS & MERGERS
2.7.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS
2.8. MARKET DRIVERS
2.8.1. ONGOING RESEARCH IN GENOMICS DUE TO THE PREVALENCE OF CHRONIC DISEASES
2.8.2. ADVANCES IN GENOMICS AFTER THE LAUNCH OF NEW TECHNOLOGIES
2.9. MARKET CHALLENGES
2.9.1. SOCIAL AND ETHICAL ISSUES RELATED TO DATA PRIVACY
2.9.2. LACK OF PROFESSIONALS IN DEVELOPING COUNTRIES
2.10. MARKET OPPORTUNITIES
2.10.1. FUNDING BY MANUFACTURERS AND GOVERNMENT IN GENOMICS
2.10.2. GROWING DEMAND FOR THIRD-GENERATION SEQUENCING

3. ASIA-PACIFIC SEQUENCING REAGENTS MARKET – BY APPLICATION
3.1. ONCOLOGY
3.2. CLINICAL INVESTIGATION
3.3. AGRI GENOMICS AND FORENSICS
3.4. REPRODUCTIVE HEALTH
3.5. OTHER APPLICATIONS

4. ASIA-PACIFIC SEQUENCING REAGENTS MARKET – BY REAGENT TYPE
4.1. SEQUENCING KITS
4.2. CONTROL KITS
4.3. LIBRARY KITS
4.4. TEMPLATE KITS
4.5. OTHER REAGENT TYPES

5. ASIA-PACIFIC SEQUENCING REAGENTS MARKET – BY TECHNOLOGY
5.1. NEXT-GENERATION SEQUENCING
5.2. SANGER SEQUENCING
5.3. THIRD-GENERATION SEQUENCING

6. ASIA-PACIFIC SEQUENCING REAGENTS MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH INSTITUTES
6.2. HOSPITALS AND CLINICS
6.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
6.4. OTHER INDUSTRY VERTICALS

7. ASIA-PACIFIC SEQUENCING REAGENTS MARKET – COUNTRY OUTLOOK
7.1. COUNTRY ANALYSIS
7.1.1. CHINA
7.1.2. JAPAN
7.1.3. INDIA
7.1.4. AUSTRALIA & NEW ZEALAND
7.1.5. SOUTH KOREA
7.1.6. ASEAN COUNTRIES
7.1.7. REST OF ASIA-PACIFIC

8. COMPANY PROFILE
8.1. AGILENT TECHNOLOGIES INC
8.2. ASURAGEN INC
8.3. BGI GENOMICS
8.4. BIO RAD LABORATORIES INC
8.5. F HOFFMANN-LA ROCHE
8.6. FLUIDIGM CORPORATION
8.7. ILLUMINA INC
8.8. LGC BIOSEARCH TECHNOLOGIES
8.9. MERCK KGAA
8.10. PACIFIC BIOSCIENCES OF CALIFORNIA INC
8.11. PERKINELMER INC
8.12. QIAGEN NV
8.13. TAKARA BIO INC
8.14. THERMO FISHER SCIENTIFIC INC
8.15. TRILINK BIOTECHNOLOGIES INC

9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1. OBJECTIVES OF STUDY
9.1.2. SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1. PRIMARY DATA SOURCES
9.2.2. SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1. EVALUATION OF PROPOSED MARKET
9.3.2. IDENTIFICATION OF DATA SOURCES
9.3.3. ASSESSMENT OF MARKET DETERMINANTS
9.3.4. DATA COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS

LIST OF TABLES

TABLE 1: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 4: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS & MERGERS
TABLE 6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 2: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 3: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY CLINICAL INVESTIGATION, 2021-2028 (IN $ MILLION)
FIGURE 4: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY AGRI GENOMICS AND FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 5: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2020 & 2028 (IN %)
FIGURE 8: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY SEQUENCING KITS, 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY LIBRARY KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY TEMPLATE KITS, 2021-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY OTHER REAGENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 14: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY NEXT-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY SANGER SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY THIRD-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 18: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY HOSPITALS AND CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 22: CHINA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: JAPAN SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: INDIA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: AUSTRALIA & NEW ZEALAND SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: SOUTH KOREA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: ASEAN COUNTRIES SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: REST OF ASIA-PACIFIC SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)

The post ASIA-PACIFIC SEQUENCING REAGENTS MARKET 2021-2028 first appeared on CRI Report.